Remove 2023 Remove Packaging Remove Pharmaceutical Companies
article thumbnail

Europe’s pharmaceutical packaging market to value over $35bn by 2028

European Pharmaceutical Review

Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent between the forecast period: 2023 and 2028. Having been valued at $27.04

Packaging 118
article thumbnail

How ready are you? Preparing for the impact of EU GMP Annex 1 on primary packaging

European Pharmaceutical Review

While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing Practice (GMP) Annex 1 effectively reset the benchmark for quality standards across the globe on 25 August 2023. Register your details to read more The post How ready are you?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Rising Demand for Pharmaceutical Secondary Packaging Providers

Roots Analysis

In addition, over the next five years, the global pharmaceutical market is projected to grow at a CAGR of 4.7%, with global drug sales anticipated to raise revenues worth USD 1.5 trillion in 2023. 3] Some of the advantages offered by pharmaceutical secondary packaging have been depicted below.

article thumbnail

STAT+: Pharmalittle: We’re reading about the FDA listing Novo drugs as ‘available,’ pharma layoffs, and more

STAT

Of course, this calls for a cup of stimulation, and we are opening a new package of pecan pie for the occasion. pharmaceutical industry fell last month, although the number of job cuts remains well above what was seen at the same time in 2023,  according to Challenger, Gray & Christmas, the outplacement and executive coaching firm.

article thumbnail

STAT+: Pharmalittle: We’re reading about China detaining AstraZeneca staff, pharma layoffs, and more

STAT

This calls for celebration with a cup of stimulation, and we are opening a new package of salted caramel for the occasion. This was also well above the 783 jobs the industry slashed in August 2023. What is upon us right now, however, is our ever-growing to-do list. Sound familiar? So here are some items of interest.

article thumbnail

Janssen rebrands its identity

European Pharmaceutical Review

The Janssen Pharmaceutical Companies of Johnson & Johnson has changed its name to Johnson & Johnson Innovative Medicine (J&J Innovative Medicine). This new re-brand for the company follows the appointment its new Executive Vice President, Pharmaceuticals, R&D, an ex- Sanofi executive, in February 2023.

article thumbnail

PDA revises report on glass container manufacturing

European Pharmaceutical Review

Revised for 2023, the Parenteral Drug Association (PDA) has published an update to its Technical Report No. 43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for Pharmaceutical Manufacturing.